306 related articles for article (PubMed ID: 18230976)
1. Cutaneous graft-versus-host disease: a guide for the dermatologist.
Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-versus-host disease: clinical manifestation and therapy.
Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
[TBL] [Abstract][Full Text] [Related]
4. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
5. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
6. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
Vogelsang GB; Lee L; Bensen-Kennedy DM
Annu Rev Med; 2003; 54():29-52. PubMed ID: 12359826
[TBL] [Abstract][Full Text] [Related]
9. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
10. GVHD pathophysiology: is acute different from chronic?
Toubai T; Sun Y; Reddy P
Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
[TBL] [Abstract][Full Text] [Related]
11. Oral graft-versus-host disease.
Schubert MM; Correa ME
Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
[TBL] [Abstract][Full Text] [Related]
12. PUVA therapy for chronic cutaneous graft-vs-host disease.
Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of acute GvHD.
Messina C; Faraci M; de Fazio V; Dini G; Calò MP; Calore E;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S65-70. PubMed ID: 18545247
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease of the skin: life and death on the epidermal edge.
Hofmeister CC; Quinn A; Cooke KR; Stiff P; Nickoloff B; Ferrara JL
Biol Blood Marrow Transplant; 2004 Jun; 10(6):366-72. PubMed ID: 15148490
[TBL] [Abstract][Full Text] [Related]
15. T cell immunity and graft-versus-host disease (GVHD).
Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
[TBL] [Abstract][Full Text] [Related]
16. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J; Subbiah S; Lazarus HM; van Besien K
Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
[TBL] [Abstract][Full Text] [Related]
17. Colonic graft-versus-host disease.
Ross WA; Couriel D
Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
20. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.
Schaffer JV; McNiff JM; Seropian S; Cooper DL; Bolognia JL
J Am Acad Dermatol; 2005 Oct; 53(4):591-601. PubMed ID: 16198778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]